Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project--Cooperative Agreements (U01)
Project #
3U01HL042824-05S1
Application #
3553368
Study Section
Special Emphasis Panel (SRC (KG))
Project Start
1989-08-01
Project End
1994-07-31
Budget Start
1994-03-15
Budget End
1994-07-31
Support Year
5
Fiscal Year
1994
Total Cost
Indirect Cost

  Institution

Name
University of Washington
Department
Type
Schools of Public Health
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195

  Publications

Slichter, Sherrill J; Bolgiano, Douglas; Kao, Kuo-Jang et al. (2011) Persistence of lymphocytotoxic antibodies in patients in the trial to reduce alloimmunization to platelets: implications for using modified blood products. Transfus Med Rev 25:102-10
Slichter, Sherrill J; Davis, Kathryn; Enright, Helen et al. (2005) Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood 105:4106-14
Enright, Helen; Davis, Kathryn; Gernsheimer, Terry et al. (2003) Factors influencing moderate to severe reactions to PLT transfusions: experience of the TRAP multicenter clinical trial. Transfusion 43:1545-52
Olivieri, N F; Brittenham, G M (1998) Long-term trials of deferiprone in Cooley's anemia. Ann N Y Acad Sci 850:217-22
Olivieri, N F; Brittenham, G M; Matsui, D et al. (1995) Iron-chelation therapy with oral deferipronein patients with thalassemia major. N Engl J Med 332:918-22
Brittenham, G M (1994) New advances in iron metabolism, iron deficiency, and iron overload. Curr Opin Hematol 1:101-6